However, clinicians must also consider potential adverse effects, evaluate the cost-effectiveness of these medications for each patient, and closely monitor for any improvement or worsening of eating disorders and related side effects
Semaglutide works on GLP-1 receptors only, while tirzepatide targets both GLP-1 and GIP receptors
For laboratory research only
Either you must have a body mass index (BMI) of 30 or over or have a BMI measuring 27 or above with a weight-related health condition, such as: High blood pressure High cholesterol Type 2 diabetes Sleep apnea Heart disease We calculate your BMI based on your height and weight
Serious potential risks documented in prescribing information include pancreatitis, gallbladder problems, kidney injury related to dehydration, and allergic reactions
"Or, they want me to be having another baby